NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

iPS細胞 (誘導性多功能幹細胞):全球市場

Induced Pluripotent Stem Cells: Global Markets

出版商 BCC Research 商品編碼 1014810
出版日期 內容資訊 英文 142 Pages
訂單完成後即時交付
價格
iPS細胞 (誘導性多功能幹細胞):全球市場 Induced Pluripotent Stem Cells: Global Markets
出版日期: 2021年06月15日內容資訊: 英文 142 Pages
簡介

全球iPS細胞的市場規模,從2021年的28億美元,至2026年達44億美元預計,還有2021年到2026年的年複合成長率(CAGR) 預計為9.3%。

本報告提供全球iPS細胞 (誘導性多功能幹細胞)的市場相關分析,產品、技術概要和市場基本結構,主要的推動及阻礙市場要素,市場規模、成長率、市場佔有率趨勢預測,各地區、各產品功能、各用途詳細趨勢,法規制定、技術開發的動向,主要企業的簡介,新型冠狀病毒感染疾病 (COVID-19) 的影響等彙整資訊,為您概述為以下內容。

目錄

第1章 簡介

第2章 摘要、亮點

  • 市場成長的主要推動要素

第3章 市場概要

  • 簡介
  • 歷史和現狀
  • iPS細胞分析的發展
  • iPS細胞的優點與缺點
  • 優點
  • 缺點
  • 技術概要
  • iPS細胞的生成
  • iPS細胞的分化
  • 對iPS細胞的有效利用方法的目前課題
  • iPS細胞庫

第4章 新型冠狀病毒感染疾病 (COVID-19) 感染擴大的影響

  • 簡介
  • MedTech的影響
  • 選擇性/不重要的手術
  • 製造業的轉移
  • 法規的延遲,臨床試驗,產品銷售
  • 供應鏈的混亂
  • 醫療觀光
  • COVID-19對iPS細胞的影響
  • COVID-19研究模式的多功能幹細胞
  • 使用了幹細胞,COVID-19對心臟的影響的闡明

第5章 iPS細胞的應用領域

  • 教育、研究
  • 藥理學性、毒性篩檢
  • 藥物研發、開發
  • 疾病的建模
  • 人組織工程
  • 細胞治療

第6章 iPS細胞市場明細與預測

  • 市場概要
  • 美國
  • 歐洲
  • 亞太地區
  • 市場概要:用途為基礎
  • iPS細胞產品的市場
  • iPS細胞來源的組織細胞的市場
  • iPS細胞來源的組織細胞的市場:類別
  • 全球市場
  • iPS細胞產品的主要供應商、廠商
  • iPS細胞來源細胞的市場:各用途
  • iPS細胞市場:各產品功能
  • 全球市場
  • 地區市場
  • 研究市場與臨床市場比較

第7章 iPS細胞市場:各用途分析

  • iPS細胞分析:各產品種類
  • 主要企業
  • 主要的營利團體
  • 主要的非營利團體
  • 市場佔有率與其預測

第8章 iPS細胞契約服務市場

  • iPS細胞契約服務的種類
  • 主要企業
  • 市場佔有率與其預測

第9章 研究市場趨勢分析

  • 津貼分析
  • 專利分析
  • 科學出版物分析

第10章 臨床應用市場趨勢分析

  • 臨床試驗
  • 老年性黃斑部病變
  • 缺血性心臟疾病
  • 帕金森氏症
  • 移植物抗宿主病 (GvHD)
  • 脊髓損傷
  • 角膜修復
  • 癌症
  • 促進因素
  • 阻礙因素
  • 技術
  • 規則
  • 市場上的接受
  • 臨床效率

第11章 競爭情形

  • 企業合併、收購 (M&A)
  • 策略性聯盟

第12章 企業簡介

  • ADDGENE
  • ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INC.
  • ALSTEM
  • APPLIED BIOLOGICAL MATERIALS INC.(ABM)
  • APPLIED STEMCELL INC.(ASC)
  • ATCC
  • AXOL BIOSCIENCE‎LTD.
  • BIO-TECHNE
  • BLUEROCK THERAPEUTICS
  • BRISTOL-MYERS SQUIBB(IPIERIAN)
  • CELL SIGNALING TECHNOLOGY(CST)
  • CORNING INC.
  • CREATIVE BIOARRAY‎
  • FATE THERAPEUTICS
  • FUJIFILM CELLULAR DYNAMICS INC.(FCDI)
  • GENECOPOEIA
  • GENTARGET INC.
  • ID PHARMA CO., LTD.
  • INVIVOGEN
  • LONZA GROUP LTD.
  • MEGAKARYON CORP.
  • MERCK KGaA
  • MTI-GLOBALSTEM, A PART OF THERMO FISHER SCIENTIFIC
  • NCARDIA
  • NEWCELLS BIOTECH
  • PEPROTECH
  • PLASTICELL LTD.
  • PROMEGA CORP.
  • PROMOCELL GMBH
  • QIAGEN N.V.
  • REPROCELL INC.
  • SCIENCELL RESEARCH LABORATORIES
  • STEMCELL TECHNOLOGIES‎
  • SYSTEM BIOSCIENCES INC.
  • TAKARA BIO USA INC.(CLONTECH LABORATORIES)
  • THERMO FISHER SCIENTIFIC
  • VIACYTE INC.
  • WAISMAN BIOMANUFACTURING

第13章 附錄:縮寫一覽

目錄
Product Code: BIO135D

Highlights:

The global market for induced pluripotent stem cells should grow from $2.8 billion in 2021 to $4.4 billion by 2026, at compound annual growth rate (CAGR) of 9.3% for the period of 2021-2026.

U.S. market for induced pluripotent stem cells should grow from $1.4 billion in 2021 to $2.1 billion by 2026, at a CAGR of 8.6% for the period of 2021-2026.

Asia-Pacific market for induced pluripotent stem cells should grow from $636.9 million in 2021 to $1.0 billion by 2026, at a CAGR of 10.5% for the period of 2021-2026.

Report Scope

This study focuses on the market side of iPSCs rather than its technical side. Different market segments for this emerging market are covered. For instance, product function-based market segments include molecular and cellular engineering, cellular reprogramming, cell culture, cell differentiation, and cell analysis. Application-based market segments include drug development and toxicity testing, academic research, and regenerative medicine. iPSC-derived cell-type-based market segments include hepatocytes, neurons, cardiomyocytes, endothelial cells, and other cell types. Other cell types are comprised of astrocytes, fibroblasts, hematopoietic progenitor cells, etc. Geographical-based market segments include the U.S., Asia-Pacific, Europe, and the Rest of the World. The research and market trends are also analyzed by studying the funding, patent publications and research publications in the field.

This report focuses on the market size and segmentation of iPSC products, including iPSC research and clinical products. The market for iPSC-related contract services is also discussed. iPSC research products are defined as all research tools, including iPSCs and various differentiated cells derived from iPSCs, various related assays and kits, culture media and medium components (e.g., serum, growth factors, inhibitors), antibodies, enzymes, and products that can be applied for the specific purpose of executing iPSC research. For this report, iPSC products do not cover stem cell research and clinical products, which are broadly applicable to any stem cell type.

This report discusses key manufacturers, technologies and factors influencing market demand, including the driving forces and limiting factors of the iPSCs market growth. Based on these facts and analysis, the market trends and sales for research and clinical applications are forecast through 2026. One particular focus on the application of iPSCs was given to drug discovery and development, which includes pharmaco-toxicity screening, lead generation, target identification, and other preclinical studies, body-on-a-chip, and 3D disease modeling. Suppliers and manufacturers of iPSC-related products are discussed and analyzed based on their market shares, product types, and geography. An in-depth patent analysis and research funding analysis are also included to assess the overall direction of the iPSCs market.

The detailed technologies such as those for generating iPSCs, differentiating iPSCs, controlling the differentiation, and large-scale manufacturing of iPSCs and their derivative cells under GMP compliance or xeno-free conditions are excluded from the study, as they are beyond the scope of this report.

Report Includes

  • 43 tables
  • An updated review of the global market for induced pluripotent stem cells (iPSC) within the industry
  • Analyses of the global market trends, with data from 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
  • Estimation of the market size and revenue forecast for the iPSCs market, and corresponding market share analysis by market segments such as application, reprogramming method, iPSCs generation method, product function and geography
  • Highlights of emerging technology trends, market opportunities and deterrents estimating current and future demand of iPSC-related products and their derivatives for drug discovery
  • Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages
  • Discussion of market dynamics that impact the growth of the market for iPSCs, clinical applications, market regulations, industry structure, and penetration of technologies within the biotech industry
  • Insight into the segmentation of iPSC products, including iPSC research and clinical products, along with application-based segments such as academic research, drug development and regenerative medicine as well as iPSC-related contract services
  • Number of global (+ the U.S.) patents and patent applications on induced pluripotent stem cells, and corresponding iPSC scientific publications during the period of 2008-October 2019
  • Competitive landscape of the key manufacturers and suppliers in the iPSC market, their competitive environment and major growth strategies within the global market
  • Descriptive company profiles of leading industry players, including Applied Biological Materials Inc., Bristol-Myers Squibb, Corning Inc., Merck KGaA and Thermo Fisher Scientific

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

  • Key Drivers for Market Growth

Chapter 3 Market Overview

  • Introduction
  • History and Current State
  • Evolution of Induced Pluripotent Stem Cell Research
  • Advantages and Disadvantages of Induced Pluripotent Stem Cells
  • Advantages
  • Disadvantages
  • Technology Overview
  • Induced Pluripotent Stem Cell Generation
  • Induced Pluripotent Stem Cell Differentiation
  • Current Challenges to iPSC Applications
  • iPSCs Bank

Chapter 4 Impact of COVID-19 Pandemic

  • Introduction
  • Impact on MedTech
  • Elective and Noncritical Procedures
  • Shift in Manufacturing
  • Regulatory Delays, Clinical Trials and Product Launches
  • Supply Chain Disruptions
  • Medical Tourism
  • Impact of COVID-19 on iPSCs
  • Pluripotent Stem Cells as a Study Model for COVID-19
  • Scientists Use Stem Cells to Uncover COVID-19 Effects on the Heart

Chapter 5 Induced Pluripotent Stem Cell Applications

  • Academic Research
  • Pharmaco-Toxicological Screening
  • Drug Discovery and Development
  • Disease Modeling
  • Tissue Engineering
  • Cell Therapy

Chapter 6 Induced Pluripotent Stem Cells Market Segmentation and Forecast

  • Market Overview
  • U.S.
  • Europe
  • Asia-Pacific
  • Application-Based Market Overview
  • Induced Pluripotent Stem Cells Product Market
  • Induced Pluripotent Stem Cell-Derived Tissue Cell Market
  • Induced Pluripotent Stem Cells and Their Derivative Cell Market by Species
  • Global Market
  • Major Suppliers and Manufacturers of Induced Pluripotent Stem Cell Products
  • Market for Induced Pluripotent Stem Cell-Derived Cells by Application
  • Market for Induced Pluripotent Stem Cells by Product Function
  • Global Market
  • Regional Markets
  • Research Market Compared with the Clinical Market

Chapter 7 Induced Pluripotent Stem Cells Research Application Market

  • Induced Pluripotent Stem Cells Research Product Types
  • Major Players
  • Major Commercial Entities
  • Major Noncommercial Organizations
  • Market Shares and Projections

Chapter 8 Induced Pluripotent Stem Cell Contract Service Market

  • Induced Pluripotent Stem Cell Contract Service Types
  • Major Players
  • Market Shares and Projections

Chapter 9 Research Market Trend Analysis

  • Grant Analysis
  • Patent Analysis
  • Scientific Publication Analysis

Chapter 10 Clinical Application Market Trend Analysis

  • Clinical Trials
  • Age-Related Macular Degeneration
  • Ischemic Heart Disease
  • Parkinson's Disease
  • Graft-versus-Host Disease (GvHD)
  • Spinal Cord Injuries
  • Cornea Repair
  • Cancers
  • Driving Forces
  • Limiting Factors
  • Technologies
  • Regulations
  • Market Acceptance
  • Clinical Efficiency

Chapter 11 Competitive Landscape

  • Mergers and Acquisitions
  • Strategic Alliances

Chapter 12 Company Profiles

  • ADDGENE
  • ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INC.
  • ALSTEM
  • APPLIED BIOLOGICAL MATERIALS INC. (ABM)
  • APPLIED STEMCELL INC. (ASC)
  • ATCC
  • AXOL BIOSCIENCE‎ LTD.
  • BIO-TECHNE
  • BLUEROCK THERAPEUTICS
  • BRISTOL-MYERS SQUIBB (IPIERIAN)
  • CELL SIGNALING TECHNOLOGY (CST)
  • CORNING INC.
  • CREATIVE BIOARRAY‎
  • FATE THERAPEUTICS
  • FUJIFILM CELLULAR DYNAMICS INC. (FCDI)
  • GENECOPOEIA
  • GENTARGET INC.
  • ID PHARMA CO., LTD.
  • INVIVOGEN
  • LONZA GROUP LTD.
  • MEGAKARYON CORP.
  • MERCK KGaA
  • MTI-GLOBALSTEM, A PART OF THERMO FISHER SCIENTIFIC
  • NCARDIA
  • NEWCELLS BIOTECH
  • PEPROTECH
  • PLASTICELL LTD.
  • PROMEGA CORP.
  • PROMOCELL GMBH
  • QIAGEN N.V.
  • REPROCELL INC.
  • SCIENCELL RESEARCH LABORATORIES
  • STEMCELL TECHNOLOGIES‎
  • SYSTEM BIOSCIENCES INC.
  • TAKARA BIO USA INC. (CLONTECH LABORATORIES)
  • THERMO FISHER SCIENTIFIC
  • VIACYTE INC.
  • WAISMAN BIOMANUFACTURING

Chapter 13 Appendix: List of Acronyms

List of Tables

  • Summary Table : Global Market for Induced Pluripotent Stem Cells, by Country/Region, Through 2026
  • Table 1 : Pros and Cons Associated with the Use of iPSCs
  • Table 2 : iPSCs Banks Worldwide, 2019
  • Table 3 : Global Market for Induced Pluripotent Stem Cells, by Country/Region, Through 2026
  • Table 4 : U.S. Market for Induced Pluripotent Stem Cells, by State, Through 2026
  • Table 5 : European Market for Induced Pluripotent Stem Cells, by Country, Through 2026
  • Table 6 : Asia-Pacific Market for Induced Pluripotent Stem Cells, by Country, Through 2026
  • Table 7 : Global Market for the Generation of Induced Pluripotent Stem Cells, by Reprogramming Method, Through 2026
  • Table 8 : Global Market for the Generation of Induced Pluripotent Stem Cells, by Method, Through 2026
  • Table 9 : Global Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
  • Table 10 : U.S. Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
  • Table 11 : European Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
  • Table 12 : Asia-Pacific Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
  • Table 13 : Rest of the World Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
  • Table 14 : Global Market for Induced Pluripotent Stem Cell-Derived Tissue Cells, by Type, Through 2026
  • Table 15 : Global Market for Induced Pluripotent Stem Cell-Derived Cells, by Species, Through 2026
  • Table 16 : Major Commercial Suppliers of Induced Pluripotent Stem Cells Products, by Country
  • Table 17 : Major Commercial Manufacturers of Induced Pluripotent Stem Cells, by Country
  • Table 18 : Global Market for Induced Pluripotent Stem Cell-Derived Cells, by Application, Through 2026
  • Table 19 : Global Market for Induced Pluripotent Stem Cell-Related Products, by Product Function, Through 2026
  • Table 20 : U.S. Market for Induced Pluripotent Stem Cell-Related Products, by Product Function, Through 2026
  • Table 21 : European Market for Induced Pluripotent Stem Cell-Related Products, by Product Function, Through 2026
  • Table 22 : Asia-Pacific Market for Induced Pluripotent Stem Cell-Related Products, by Product Function, Through 2026
  • Table 23 : RoW Market for Induced Pluripotent Stem Cell-Related Products, by Product Function, Through 2026
  • Table 24 : Global Market for Induced Pluripotent Stem Cells in Research and Clinical Uses, Through 2026
  • Table 25 : Global Market for Induced Pluripotent Stem Cell-Related Products, by Function, Through 2026
  • Table 26 : Major University and Institute Facilities for Induced Pluripotent Stem Cell Core, by Location/Country
  • Table 27 : Major Companies Providing iPSC Contract Services, by State/Country
  • Table 28 : Global Market for Induced Pluripotent Stem Cell Contract Services, by Country/Region, Through 2026
  • Table 29 : Major Governmental Induced Pluripotent Stem Cells Research Funding and Share, by Country/Region, 2006-October 2019
  • Table 30 : National Institutes of Health Induced Pluripotent Stem Cells Research Funding, 2006-October 2019
  • Table 31 : California Institute of Regenerative Medicine Induced Pluripotent Stem Cells Funding, October 2019
  • Table 32 : U.S. Patents on Induced Pluripotent Stem Cells
  • Table 33 : Number and Share of Global Patents or Patent Applications on Induced Pluripotent Stem Cells, by Country, October 2019
  • Table 34 : Distribution of Patents and Patent Applications on Induced Pluripotent Stem Cells, by Patent Office or Country, October 2019
  • Table 35 : Main Inventors Listed on Global Patents or Patent Applications on Induced Pluripotent Stem Cells, October 2019
  • Table 36 : Main Applicants Listed on Global Patents or Patent Applications on Induced Pluripotent Stem Cells, October 2019
  • Table 37 : Global Patents and Patent Applications on Induced Pluripotent Stem Cells, by Year, 2008-October 2019
  • Table 38 : U.S. Patents on Induced Pluripotent Stem Cells, 2009-October 2019
  • Table 39 : Global Patents and Patent Applications Filed with the USPTO on Induced Pluripotent Stem Cells, by Assignee's Country, October 2019
  • Table 40 : U.S. Patents and Share on Induced Pluripotent Stem Cells, by U.S. State, October 2019
  • Table 41 : Scientific Publications of Induced Pluripotent Stem Cells Research, 2006-October 2019
  • Table 42 : Acronyms Used in the iPSCs Industry

List of Figures

  • Summary Figure A : Global Market for Induced Pluripotent Stem Cells, by Country/Region, 2020-2026
  • Summary Figure B : Global Market Shares of Induced Pluripotent Stem Cells, by Country/Region, 2020
  • Figure 1 : Global Market Shares of Induced Pluripotent Stem Cells, by Country/Region, 2020
  • Figure 2 : U.S. Market Shares of Induced Pluripotent Stem Cells, by State, 2020
  • Figure 3 : European Market Shares of Induced Pluripotent Stem Cells, by Country, 2020
  • Figure 4 : Asia-Pacific Market Shares of Induced Pluripotent Stem Cell Products, by Country, 2020
  • Figure 5 : Global Market Shares of the Generation of Induced Pluripotent Stem Cells, by Reprogramming Method, 2020
  • Figure 6 : Global Market Shares of the Generation of Induced Pluripotent Stem Cells, by Method, 2020
  • Figure 7 : Global Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
  • Figure 8 : U.S. Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
  • Figure 9 : European Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
  • Figure 10 : Asia-Pacific Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
  • Figure 11 : Rest of the World Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
  • Figure 12 : Global Market Shares of Induced Pluripotent Stem Cell-Derived Tissue Cells, by Type, 2020
  • Figure 13 : Global Market Shares of Induced Pluripotent Stem Cell-Derived Cells, by Application, 2020
  • Figure 14 : Global Market Shares of Induced Pluripotent Stem Cell-Related Products, by Product Function, 2020
  • Figure 15 : U.S. Market Shares of Induced Pluripotent Stem Cell-Related Products, by Product Function, 2020
  • Figure 16 : European Market Shares of Induced Pluripotent Stem Cell-Related Products, by Product Function, 2020
  • Figure 17 : Asia-Pacific Market Shares of Induced Pluripotent Stem Cell-Related Products, by Product Function, 2020
  • Figure 18 : RoW Market Shares of Induced Pluripotent Stem Cell-Related Products, by Product Function, 2020
  • Figure 19 : Global Market Shares of Induced Pluripotent Stem Cells in Research and Clinical Uses, 2020
  • Figure 20 : Global Market Shares of Induced Pluripotent Stem Cell-Related Products, by Function, 2020
  • Figure 21 : Global Market Shares of Induced Pluripotent Stem Cell Contract Services, by Country/Region, 2020
  • Figure 22 : National Institutes of Health Funding Amounts for Induced Pluripotent Stem Cells Research, 2006-October 2019
  • Figure 23 : Number of Global Patents and Patent Applications on Induced Pluripotent Stem Cells, 2008-October 2019
  • Figure 24 : Number of U.S. Patents on Induced Pluripotent Stem Cells, 2009-October 2019
  • Figure 25 : Scientific Publications of Induced Pluripotent Stem Cell Research, 2006-October 2019
  • Figure 26 : Bio-Techne: Annual Revenue, 2018-2020
  • Figure 27 : Bio-Techne: Revenue Share, by Country/Region, 2020
  • Figure 28 : Bio-Techne: Revenue Share, by Business Segment, 2020
  • Figure 29 : Bristol-Myers Squibb: Annual Revenue, 2018-2020
  • Figure 30 : Bristol-Myers Squibb: Revenue Share, by Country/Region, 2020
  • Figure 31 : Corning Inc.: Annual Revenue, 2018-2020
  • Figure 32 : Corning Inc.: Revenue Share, by Business Segment, 2020
  • Figure 33 : Thermo Fisher Scientific: Annual Revenue, 2019 and 2020
  • Figure 34 : Thermo Fisher Scientific: Revenue Share, by Segment, 2020